SCHEMBL16627355

SCHEMBL16627355

CC(=O)OC[C@H](OC(C)=O)C(OC(C)=O)C(CO)OC(C)=O

nearest known ligand 0.75

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.75
ABCB1 P08183 1/20 0.47
POLB P06746 1/20 0.43
MAPK1 P28482 1/20 0.43
PRKCA P17252 4/20 0.35
LMNA P02545 2/20 0.33
ALDH1A1 P00352 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TSHR P16473 1/20 0.33
TRPV1 Q8NER1 1/20 0.33
AR P10275 1/20 0.32
USP2 O75604 1/20 0.32
CYP3A4 P08684 1/20 0.32
MAPT P10636 1/20 0.32
RECQL P46063 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PGD P52209 1/20 0.32
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL813363 1.00 TDP1 (0.75) TDP1ABCB1POLBMAPK1PRKCA
SCHEMBL16312958 0.96 TDP1 (0.81) TDP1ABCB1POLBMAPK1PRKCA
SCHEMBL7154355 0.92 TDP1 (0.88) TDP1ABCB1POLBMAPK1LMNA
SCHEMBL7146329 0.92 TDP1 (0.88) TDP1ABCB1POLBMAPK1LMNA
SCHEMBL187068 0.92 TDP1 (0.88) TDP1ABCB1POLBMAPK1LMNA
SCHEMBL15298821 0.92 TDP1 (0.88) TDP1ABCB1POLBMAPK1LMNA
SCHEMBL2175855 0.88 TDP1 (0.96) TDP1ABCB1POLBMAPK1LMNA
SCHEMBL270042 0.88 TDP1 (0.96) TDP1ABCB1POLBMAPK1LMNA
SCHEMBL826717 0.88 TDP1 (0.96) TDP1ABCB1POLBMAPK1LMNA
SCHEMBL7149374 0.88 TDP1 (0.96) TDP1ABCB1POLBMAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150098903-A1 Compounds and Compositions for the Detection and Treatment of Alzheimer's Disease and Related Disorders THE GENERAL HOSPITAL CORPORATION 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150098903-A1 Compounds and Compositions for the Detection and Treatment of Alzheimer's Disease and Related Disorders APP, PSEN1, PSEN2 TDP1 1128/4885ABCB1 305/4885POLB 3800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.